James Mcnulty

Insider Reports History

Entity
Individual
Location
C/O Cv Sciences, Inc., 2688 S. Rainbow Blvd., Suite B, Las Vegas, NV
Signature
/s/ James McNulty
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by James Mcnulty:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Inhibitor Therapeutics, Inc. CHIEF FINANCIAL OFFICER, 10%+ Owner Common Stock 26.1M May 5, 2023 Indirect
Inhibitor Therapeutics, Inc. CHIEF FINANCIAL OFFICER, 10%+ Owner Common Stock 946K May 5, 2023 Direct
RENOVARO INC. Director Option to purchase shares of common stock 121K Nov 4, 2024 Direct
Inhibitor Therapeutics, Inc. CHIEF FINANCIAL OFFICER, 10%+ Owner Stock Option 100K Mar 16, 2024 Direct

Insider Reports Filed by James Mcnulty

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RENB RENOVARO INC. Nov 4, 2024 1 $0 4 Nov 6, 2024 Director
RENB RENOVARO INC. Oct 14, 2024 0 $0 3 Oct 23, 2024 Director
INTI Inhibitor Therapeutics, Inc. Mar 16, 2024 1 $0 4 May 16, 2024 CHIEF FINANCIAL OFFICER, 10%+ Owner
INTI Inhibitor Therapeutics, Inc. May 5, 2023 3 $0 4 May 17, 2023 Chief Financial Officer, Treasurer, Secretary of the Company, 10%+ Owner
INTI Inhibitor Therapeutics, Inc. Dec 13, 2022 0 $0 3 Dec 22, 2022 Chief Financial Officer, Treasurer, Secretary of the Company, 10%+ Owner